Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome
Authors:
- Haiyan WangHWHaiyan Wang
- Zhi-Chao SunZSZhi-Chao Sun
- Chunlei DaiCDChunlei Dai
- Ran LiaoRLRan Liao
- Ran LinRLRan Lin
- Liying WangLWLiying Wang
- Wenjun FuWFWenjun Fu
- Ruhe ZhangRZRuhe Zhang
- Danwen ZhengDZDanwen Zheng
- Zhongde ZhangZZZhongde Zhang
- Jun WuJWJun Wu
- Yuntao LiuYLYuntao Liu
Open Access
- 5 November 2025
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (1) , 596-615
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou University of Chinese Medicine (GZY2025GB0410)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (ZYYCXTD-D-202203)
- National Natural Science Foundation of China (82374392)
- National Natural Science Foundation of China (52173150)
- Traditional Chinese Medicine Bureau of Guangdong Province (20251152)
This publication has 60 references indexed in Scilit:
- The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndromeClinical and Translational Medicine, 2024
- Targeted Modulation of Redox and Immune Homeostasis in Acute Lung Injury Using a Thioether‐Functionalized DendrimerSmall, 2024
- Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applicationsAdvanced Drug Delivery Reviews, 2024
- Extracellular vesicles derived from M2‐like macrophages alleviate acute lung injury in a miR‐709‐mediated mannerJournal of Extracellular Vesicles, 2024
- Immunometabolic reprogramming of macrophages with inhalable CRISPR/Cas9 nanotherapeutics for acute lung injury interventionActa Biomaterialia, 2024
- Long-acting inhaled medicines: Present and futureAdvanced Drug Delivery Reviews, 2023
- Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung InjuryAdvanced Materials, 2023
- Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational designActa Pharmaceutica Sinica B, 2021
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- 100 Years of Drug Delivery to the Lungs2019